Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages (Q91588247)
Jump to navigation
Jump to search
scientific article published on 02 July 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages |
scientific article published on 02 July 2019 |
Statements
Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages (English)
Hao-Yu Chuang
Yu-Kai Su
Heng-Wei Liu
Shinn-Zong Lin
1 reference